Ouldali N, Son MBF, McArdle AJ, Vito O, Vaugon E, Belot A, Leblanc C, Murray NL, Patel MM, Levin M. Immunomodulatory therapy for MIS-C. Pediatrics 2023;152(1):e2022061173.

Tarsia M, Gaggiano C, Sota J, Maselli A, Bellantonio C, Guerriero S, La Torre F, Ragab G, Hegazy M, Fonollosa Calduch A. Efficacy and safety of biosimilars in pediatric non‑infectious uveitis: real‑life data from AIDA network registries. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL 2023;21(S2):260-260.

Bracaglia C, Minoia F, Kessel C, Vastert S, Pardeo M, Arduini A, Fingerhutova S, Nikishina I, Basaran O, Kiper N. Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe. ARTHRITIS & RHEUMATOLOGY 2023;75:175-176.

Channon-Wells S, Vito O, McArdle AJ, Seaby EG, Patel H, Shah P, Pazukhina E, Wilson C, Broderick C, D'souza G. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. The Lancet Rheumatology 2023;5(4):e184-e199.

Ruscitti P, Sota J, Vitale A, Lopalco G, Iannone F, Morrone M, Giardini HAM, D'Agostin MA, de Brito Antonelli IP, Almaghlouth I. The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry. Seminars in arthritis and rheumatism 2023;62:152244.

Triggianese P, Vitale A, Lopalco G, Giardini HAM, Ciccia F, Al-Maghlouth I, Ruscitti P, Sfikakis PP, Iannone F, de Brito Antonelli IP. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry. Internal and Emergency Medicine 2023;18(8):2231-2243.

Tzaneti A, Athanasopoulou E, Fessatou S, Fotis L. Chronic Nonbacterial Osteomyelitis in Inflammatory Bowel Disease. Life 2023;13(12):2347.

Vitale A, Caggiano V, Sfikakis PP, Dagna L, Lopalco G, Ragab G, La Torre F, Almaghlouth IA, Maggio MC, Sota J. Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease. Frontiers in Medicine 2023;10:1256243.

Ruscitti P, Masedu F, Vitale A, Di Cola I, Caggiano V, Di Muzio C, Cipriani P, Valenti M, Berardicurti O, Navarini L. Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry. RMD open 2023;9(4):e003419.

Vitale A, Caggiano V, Lopalco G, Giardini HMA, Ciccia F, Almaghlouth IA, Ruscitti P, Sfikakis PP, Tufan A, Dagna L. Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry. RMD open 2023;9(4):e003578.

Sapountzi E, Fotis L, Kotanidou E, Fidani L, Galli-Tsinopoulou A. Janus Kinase Inhibitors and Interstitial Lung Disease Associated With Pediatric Rheumatic Diseases: An Unexplored Field. Cureus 2023;15(12)

Fotis L, Kanellopoulos A, Papakonstantinou O. Arthritis remission with partial cartilage restoration in a 9-year-old female with hip chondrolysis following treatment with adalimumab. Modern Rheumatology Case Reports 2023;7(1):227-231.

Bracaglia C, Minoia F, Kessel C, Vastert S, Pardeo M, Arduini A, Fingerhutova S, Nikishina I, Basaran O, Kiper N. Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2023 p. 175 - 176.